LBRX: LB Pharmaceuticals Inc
Performance
LBRX +193.94%
Watchlist
Select an item
Summary
LBRX at a glance
LBRX returned +193.94% over the past year. Its worst drop in that year was -31.29%, smaller than 55% of stocks on Redstone, and its Sharpe ratio of 1.94 beats 97% of stocks on Redstone. It pays no dividends.
Current Drawdown
-8.81%
Rolling Volatility
67.61%
Actions
Metrics
Risk Indicators
Alpha117.42%
Beta0.77x
Sharpe1.94
Sortino3.41
Omega1.40
Calmar6.20
Martin11.30
Profile
About LBRX
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.5B
- Listed
- Sep 2025
- Employees
- 27
- Headquarters
- New York, NY
- Website
- lbpharma.us
Comparisons